Angiogenesis and Immunity in Renal Carcinoma: Can We Turn an Unhappy Relationship into a Happy Marriage?

The frontline treatment options for patients with metastatic renal cell carcinoma (mRCC) are evolving rapidly since the approval of combination immunotherapies by the U.S. Food and Drug Administration (USFDA) and the European Medicines Agency (EMA). In particular, in combination with vascular endoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Mennitto, Alessia, Huber, Veronica, Ratta, Raffaele, Sepe, Pierangela, de Braud, Filippo, Procopio, Giuseppe, Guadalupi, Valentina, Claps, Mélanie, Stellato, Marco, Daveri, Elena, Rivoltini, Licia, Verzoni, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231111/
https://www.ncbi.nlm.nih.gov/pubmed/32231117
http://dx.doi.org/10.3390/jcm9040930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231111/
https://www.ncbi.nlm.nih.gov/pubmed/32231117
http://dx.doi.org/10.3390/jcm9040930

Ejemplares similares